The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 0.00 (0.00%)
Spread: 12.00 (2.459%)
Open: 494.00
High: 494.00
Low: 494.00
Prev. Close: 494.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update - Nexus

18 Feb 2020 07:00

RNS Number : 2593D
B.P. Marsh & Partners PLC
18 February 2020
 

18 February 2020

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

Investee Company Update - Nexus Underwriting Management Limited

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist investor in early stage financial services businesses, is pleased to note that its investee company Nexus Underwriting Management Limited ("Nexus"), has been ranked at number 78 in The Sunday Times International Track 200 league table, which ranks Britain's 200 mid-market private companies in order of fastest growing international sales.

 

This is a prestigious group of fast growing companies across all sectors of UK business. Nexus has eight overseas offices across Europe, America and Asia. Nexus increased its international sales to £7.6m for its year ended 31st December 2018, a significant increase from £3.2m for their year ended 31st December 2016.

 

The Group holds an aggregate Nexus shareholding of 17.7% and has been invested since August 2014. Nexus is one of the largest independently owned Managing General Agencies in the UK insurance market, budgeting to write over £345m of Gross Written Premium across various specialty lines in the 2020 financial year.

 

Dan Topping, B.P. Marsh's Chief Investment Officer and Nominee Director on the Board of Nexus has said: "B.P. Marsh is pleased to note this accolade for Nexus, which is a testimony to Nexus' ability to deliver strong growth in international sales and expand their global footprint."

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE / Harriett Osmond - Investor Relations

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon (UK) Limited

Atholl Tweedie / Charles Leigh-Pemberton / Ailsa Macmaster

+44 (0)20 7886 2500

 

Financial PR

Tavistock Communications Limited

Simon Hudson / Tim Pearson

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains seventeen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

Since formation over 25 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

Since its inception B.P. Marsh has delivered an average annual compound increase in NAV of over 10% and this remains one of the Group's core goals for future years.

- Ends -

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKOBDABKDNBD
Date   Source Headline
18th Jul 20172:07 pmRNSInvestee Company Update - Nexus Underwriting
13th Jul 20175:10 pmRNSInvestee Company Update
5th Jul 20173:25 pmRNSDirector/PDMR Shareholding
30th Jun 201710:36 amRNSInvestee Company Update - Nexus Underwriting
29th Jun 20173:26 pmRNSShare Incentive Plan
28th Jun 20173:07 pmRNSNotice of AGM
19th Jun 20173:20 pmRNSInvestment
14th Jun 20173:55 pmRNSDirector/PDMR Shareholding
14th Jun 20172:56 pmRNSDirector/PDMR Shareholding
13th Jun 20171:10 pmRNSInvestment in North America
12th Jun 20174:01 pmRNSDirector/PDMR Shareholding
12th Jun 20173:56 pmRNSDirector/PDMR Shareholding
9th Jun 20177:05 amRNSDirector/PDMR Shareholding
9th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20177:00 amRNSFinal Results
25th Apr 20171:17 pmRNSDirector/PDMR Shareholding
24th Apr 20174:40 pmRNSChange of Registered Office
19th Apr 20175:40 pmRNSResult of General Meeting
12th Apr 20174:07 pmRNSBesso Disposal Update
6th Apr 20175:36 pmRNSDirector/PDMR Shareholding
5th Apr 201712:28 pmRNSPDMR Share Sale Plan
3rd Apr 201712:43 pmRNSDisposal and Notice of General Meeting
16th Mar 20174:50 pmRNSTransaction in Own Shares
15th Mar 20175:04 pmRNSShare Buy-Back Policy Update
15th Mar 20175:02 pmRNSDirector/PDMR Shareholding
15th Mar 20172:47 pmRNSTransaction in Own Shares
14th Mar 20172:16 pmRNSTransaction in Own Shares
13th Mar 20173:56 pmRNSTransaction in Own Shares
10th Mar 20176:18 pmRNSTransaction in Own Shares
3rd Mar 20173:23 pmRNSTransaction in Own Shares
3rd Mar 20173:21 pmRNSDirector/PDMR Shareholding
3rd Mar 201711:12 amRNSShare Buy-Back Policy
28th Feb 20174:17 pmRNSDisposal
17th Feb 20174:36 pmRNSInvestment
7th Feb 20177:00 amRNSTrading Update
3rd Feb 201712:30 pmRNSDirector/PDMR Shareholding
30th Jan 20177:40 amRNSInvestment
10th Jan 20171:43 pmRNSDirector/PDMR Shareholding
5th Jan 20172:46 pmRNSPortfolio Update
4th Jan 20177:00 amRNSDisposal
15th Dec 20163:55 pmRNSFurther Investment in Nexus
22nd Nov 20163:45 pmRNSInvestment
18th Oct 20167:00 amRNSInterim Results
8th Sep 20167:00 amRNSTrading Update
26th Jul 20167:00 amRNSInvestee Company update
20th Jul 20165:07 pmRNSResult of AGM
5th Jul 20166:20 pmRNSDirector/PDMR Shareholding
1st Jul 201610:52 amRNSDividend Declaration
28th Jun 20164:41 pmRNSResponse to EU Referendum Result
28th Jun 20164:39 pmRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.